Analysis of the MILES cohort reveals determinants of disease progression and treatment response in lymphangioleiomyomatosis.
Eur Respir J
; 53(4)2019 04.
Article
in En
| MEDLINE
| ID: mdl-30846465
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Lymphangioleiomyomatosis
/
Sirolimus
/
Lung Neoplasms
/
Antibiotics, Antineoplastic
Type of study:
Clinical_trials
/
Etiology_studies
/
Incidence_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Limits:
Adult
/
Female
/
Humans
/
Middle aged
Language:
En
Journal:
Eur Respir J
Year:
2019
Document type:
Article
Affiliation country:
Country of publication: